What To Expect From Herbalife’s (HLF) Q2 Earnings

Herbalife (NYSE: HLF) is set to report Q2 earnings Wednesday after market hours. Last quarter, it posted revenue of $1.32B, up 7.8% YoY, beating revenue estimates, with EPS beating but EBITDA missing. Q2 revenue is expected to rise 3.9% YoY. Analysts largely reconfirm estimates; average price target is $18.33 vs $12.73.

Original reporting
Published Aug 4, 2026, 4:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 4:38 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What To Expect From Herbalife’s (HLF) Q2 Earnings — source image
Decision brief

The 30-second read

$HLFNeutralMed
01

Why it matters

Traders can use the provided consensus revenue growth and the company’s recent pattern of revenue-estimate misses to position for earnings volatility, but there is no new fundamental disclosure beyond the scheduled event.

02

Market read

Earnings preview provides consensus revenue growth (3.9% YoY) and recent estimate behavior, implying a setup for after-hours volatility.

03

What to watch

The preview highlights revenue and EBITDA/EPS estimate dynamics, but does not discuss margins, guidance, or cash flow, which often drive the post-earnings move.

Relevance 4/10Novelty 4/10Timing: ahead of Wednesday after-hours Q2 earnings

Background

The article frames Herbalife’s upcoming Q2 earnings, referencing last quarter’s revenue beat and EPS beat but EBITDA miss, plus recent estimate reconfirmations.

Company-level read

Ticker impact

$HLFNeutralMedium confidence
Context

Herbalife (HLF) is set to report Q2 results Wednesday after market hours, with consensus revenue growth at 3.9% YoY.

Expected impact

Near-term volatility likely around the after-hours earnings release, but direction is uncertain from the article alone.

Evidence & confidence

The article provides expectations (revenue growth 3.9% YoY) and notes prior revenue misses, but it does not disclose any new company-specific development beyond the scheduled earnings timing.

Market effects

Peers’ mixed Q2 results (Medifast down, Vita Coco up then down) suggest consumer staples demand signals may be uneven, affecting read-across sentiment.

No specific regional impact described.

No global macro or cross-border catalyst described.

Counterpoint

If HLF’s revenue growth re-accelerates toward the 3.9% YoY expectation, the stock could outperform despite the company’s recent revenue-miss history.

Key entities

  • Herbalife

    Subject of the preview, scheduled to report Q2 earnings after market hours Wednesday.

  • Medifast

    Peer cited for Q2 results as a potential read-across (revenues down 27.6% YoY, beat by 5.1%).

  • Vita Coco

    Peer cited for Q2 results as a potential read-across (revenues up 28.1% YoY, topped estimates, shares down 11.4%).

Related articles

$HLFMedAI 8/10

Herbalife (NYSE:HLF) Beats Q2 CY2026 Sales Expectations

Herbalife (NYSE:HLF) reported Q2 CY2026 revenue of $1.33 billion, up 5.4% year on year and about 1.5% above Wall Street estimates, according to the company. It guided next-quarter revenue near $1.31 billion. Non-GAAP EPS was $0.51, missing consensus by 4.9%. Shares fell 3.4% to $12.16 after results.

$HLFMed

HERBALIFE LTD. (HLF): Results of Operations and Financial Condition

HERBALIFE LTD. (HLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea030059301ex99-1.htm PRESS RELEASE ISSUED BY HERBALIFE LTD. ON AUGUST 5, 2026 Exhibit 99.1 CONFIDENTIAL & PRIVILEGED Herbalife Reports Second Quarter Net Sales Growth; Marks Fourth Consecutive Quarter of Topline Expansion; Net Sales and Adjusted EBITDA 1 Exceed Guidanc

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.